EDGAR Filing Documents for 0001181151-05-000001

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001181151-05-000001

Filing Date

2005-05-06

Accepted

2005-05-06 11:46:37

Documents

Period of Report

2005-05-05

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	10844
	Complete submission text file	0001181151-05-000001.txt		12675

Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412

Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081

PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address

Business Address PHARMACEUTICAL PRODUCT DEVELOPMENT INC 3151 S 17TH ST WILMINGTON DE 28412 9102510081

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 05806142